Literature DB >> 26825981

ΔNp63 regulates cell proliferation, differentiation, adhesion, and migration in the BL2 subtype of basal-like breast cancer.

Paulina Orzol1, Marta Nekulova1, Jitka Holcakova1, Petr Muller1, Borivoj Votesek2, Philip J Coates3.   

Abstract

Triple-negative breast cancers (TNBC) comprise a heterogeneous subgroup of tumors with a generally poor prognosis. Subclassification of TNBC based on genomic analyses shows that basal-like TNBCs, specifically the basal A or BL2 subtype, are characterized by the expression of ΔNp63, a transcription factor that has been attributed a variety of roles in the regulation of proliferation, differentiation, and cell survival. To investigate the role(s) of p63 in basal-like breast cancers, we used HCC1806 cells that are classified as basal A/BL2. We show that these cells endogenously express p63, mainly as the ΔNp63α isoform. TP63 gene knockout by CRISPR resulted in viable cells that proliferate more slowly and adhere less tightly, with an increased rate of migration. Analysis of adhesion-related gene expression revealed a complex set of alterations in p63-depleted cells, with both increased and decreased adhesion molecules and adhesion substrates compared to parental cells expressing p63. Examination of the phenotype of these cells indicated that endogenous p63 is required to suppress the expression of luminal markers and maintain the basal epithelial phenotype, with increased levels of both CK8 and CK18 and a reduction in N-cadherin levels in cells lacking p63. On the other hand, the level of CK5 was not decreased and ER was not increased, indicating that p63 loss is insufficient to induce full luminal-type differentiation. Taken together, these data demonstrate that p63 exerts multiple pro-oncogenic effects on cell differentiation, proliferation and adhesion in basal-like breast cancers.

Entities:  

Keywords:  Adhesion; Basal-like breast cancer; Differentiation; p63

Mesh:

Substances:

Year:  2016        PMID: 26825981     DOI: 10.1007/s13277-016-4880-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  43 in total

1.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

Authors:  Brian D Lehmann; Joshua A Bauer; Xi Chen; Melinda E Sanders; A Bapsi Chakravarthy; Yu Shyr; Jennifer A Pietenpol
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  p63 is a p53 homologue required for limb and epidermal morphogenesis.

Authors:  A A Mills; B Zheng; X J Wang; H Vogel; D R Roop; A Bradley
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

3.  Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells.

Authors:  Annie Yang; Zhou Zhu; Philipp Kapranov; Frank McKeon; George M Church; Thomas R Gingeras; Kevin Struhl
Journal:  Mol Cell       Date:  2006-11-17       Impact factor: 17.970

Review 4.  Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes.

Authors:  Brian D Lehmann; Jennifer A Pietenpol
Journal:  J Pathol       Date:  2014-01       Impact factor: 7.996

5.  p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas.

Authors:  Irina Matos; Rozany Dufloth; Marcelo Alvarenga; Luiz Carlos Zeferino; Fernando Schmitt
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

6.  Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.

Authors:  Elsa R Flores; Shomit Sengupta; John B Miller; Jamie J Newman; Roderick Bronson; Denise Crowley; Annie Yang; Frank McKeon; Tyler Jacks
Journal:  Cancer Cell       Date:  2005-04       Impact factor: 31.743

7.  Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study.

Authors:  Mohammed A Aleskandarany; Ola H Negm; Andrew R Green; Mohamed A H Ahmed; Christopher C Nolan; Patrick J Tighe; Ian O Ellis; Emad A Rakha
Journal:  Breast Cancer Res Treat       Date:  2014-04-26       Impact factor: 4.872

8.  Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression.

Authors:  E A Rakha; M E El-Sayed; A R Green; E C Paish; A H S Lee; I O Ellis
Journal:  Histopathology       Date:  2007-03       Impact factor: 5.087

9.  The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer.

Authors:  Niamh E Buckley; Susan J Conlon; Karin Jirstrom; Elaine W Kay; Nyree T Crawford; Anthony O'Grady; Katherine Sheehan; Simon S Mc Dade; Ching-Wei Wang; Dennis J McCance; Patrick G Johnston; Richard D Kennedy; D Paul Harkin; Paul B Mullan
Journal:  Cancer Res       Date:  2011-03-01       Impact factor: 12.701

10.  ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling.

Authors:  Rumela Chakrabarti; Yong Wei; Julie Hwang; Xiang Hang; Mario Andres Blanco; Abrar Choudhury; Benjamin Tiede; Rose-Anne Romano; Christina DeCoste; Laura Mercatali; Toni Ibrahim; Dino Amadori; Nagarajan Kannan; Connie J Eaves; Satrajit Sinha; Yibin Kang
Journal:  Nat Cell Biol       Date:  2014-09-21       Impact factor: 28.824

View more
  12 in total

Review 1.  Molecular Classification and Future Therapeutic Challenges of Triple-negative Breast Cancer.

Authors:  Nikolaos Garmpis; Christos Damaskos; Anna Garmpi; Konstantinos Nikolettos; Dimitrios Dimitroulis; Evangelos Diamantis; Paraskevi Farmaki; Alexandros Patsouras; Errika Voutyritsa; Athanasios Syllaios; Constantinos G Zografos; Efstathios A Antoniou; Nikos Nikolettos; Alkiviadis Kostakis; Konstantinos Kontzoglou; Dimitrios Schizas; Afroditi Nonni
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma.

Authors:  Takashi Sato; Seungyeul Yoo; Ranran Kong; Abhilasha Sinha; Prashanth Chandramani-Shivalingappa; Ayushi Patel; Maya Fridrikh; Osamu Nagano; Takashi Masuko; Mary Beth Beasley; Charles A Powell; Jun Zhu; Hideo Watanabe
Journal:  Cancer Res       Date:  2019-09-24       Impact factor: 12.701

3.  p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.

Authors:  Philip J Coates; Rudolf Nenutil; Jitka Holcakova; Marta Nekulova; Jan Podhorec; Marek Svoboda; Borivoj Vojtesek
Journal:  Virchows Arch       Date:  2018-02-27       Impact factor: 4.064

4.  ΔNp63α expression induces loss of cell adhesion in triple-negative breast cancer cells.

Authors:  Marta Nekulova; Jitka Holcakova; Xiaolian Gu; Vaclav Hrabal; Sotiris Galtsidis; Paulina Orzol; Yajing Liu; Stella Logotheti; Vassilis Zoumpourlis; Karin Nylander; Philip J Coates; Borivoj Vojtesek
Journal:  BMC Cancer       Date:  2016-10-10       Impact factor: 4.430

5.  Co-expression network analysis of gene expression profiles of HER2+ breast cancer-associated brain metastasis.

Authors:  Feng Yuan; Wei Wang; Hongtao Cheng
Journal:  Oncol Lett       Date:  2018-10-10       Impact factor: 2.967

Review 6.  Perturbing Enhancer Activity in Cancer Therapy.

Authors:  Feda H Hamdan; Steven A Johnsen
Journal:  Cancers (Basel)       Date:  2019-05-07       Impact factor: 6.639

7.  ∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem-like cells in human ER+ and HER2+ breast cancers.

Authors:  Yajing Liu; Marta Nekulova; Rudolf Nenutil; Iva Horakova; M Virginia Appleyard; Karen Murray; Jitka Holcakova; Michaela Galoczova; Philip Quinlan; Lee B Jordan; Colin A Purdie; Borivoj Vojtesek; Alastair M Thompson; Philip J Coates
Journal:  J Pathol Clin Res       Date:  2019-12-06

Review 8.  Oncogenic Intra-p53 Family Member Interactions in Human Cancers.

Authors:  Maria Ferraiuolo; Silvia Di Agostino; Giovanni Blandino; Sabrina Strano
Journal:  Front Oncol       Date:  2016-03-31       Impact factor: 6.244

9.  The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer.

Authors:  Erik Hilborn; Olle Stål; Andrey Alexeyenko; Agneta Jansson
Journal:  Oncotarget       Date:  2017-07-10

Review 10.  STAT3, stem cells, cancer stem cells and p63.

Authors:  Michaela Galoczova; Philip Coates; Borivoj Vojtesek
Journal:  Cell Mol Biol Lett       Date:  2018-03-22       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.